Tibaray
Fremont, US · Delaware corporation
Founders & leadership
CC
Cecilia Carol MontalvoChief Executive Officer & Chief Financial Officer
LQ
Laird Q. CaganDirector
BL
Bill LooDirector
JV
James VetterDirector
PM
Peter MaximDirector
ST
Sami TantawaiDirector
Reported raises · per SEC filings
Form D private placements▶$1.3MraisedMay 2025 · 10 investors · Other TechnologyRule 506(b)
▶$1.3MraisedMay 2025 · 10 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Laird Q. CaganDirector
- Sami TantawaiDirector
- Cecilia Carol MontalvoExecutive Officer, Director
- Bill LooDirector
- James VetterDirector
- Peter MaximDirector
- Offering amount
- $5M
- Amount sold
- $1.3M
- Proceeds to insiders
- $500K
- First sale
- Mar 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 14 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| Department of Energy | Phase II | 2023 | $1.1M |
| Department of Energy | Phase II | 2022 | $1.1M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $399.6K |
| Department of Energy | Phase I | 2022 | $199.8K |
| Department of Energy | Phase I | 2021 | $200K |
| Department of Energy | Phase II | 2020 | $1M |
| Department of Energy | Phase I | 2020 | $200K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $2M |
| Department of Energy | Phase I | 2019 | $149.4K |
| Department of Energy | Phase II | 2018 | $1M |
| Department of Energy | Phase II | 2018 | $1M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $224.7K |
| Department of Energy | Phase I | 2017 | $149.2K |
| Department of Energy | Phase I | 2017 | $148.6K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.